Thyrocare Technologies Ltd (THYROCARE) — Insider Trading | 4 September 2026 (2 announcements)

4 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Insider Trading🔴 High Importance Neutral📄 PDF

2Insider Trading🔴 High Importance Neutral📄 PDF

📢 Key Event

API Holdings completed merger of Docon with API, transferring 51.02% stake in Thyrocare.

🔄 What Changed

51.02% shareholding transferred to API; effective September 3, 2026; NCLT approval on August 31, 2026.

💡 Investor Takeaway

The merger consolidates API's control over Thyrocare without altering promoter holdings.

API Holdings announced that its subsidiary Docon merged with API on September 3, 2026, transferring 8,12,00,000 shares representing 51.02% of Thyrocare's paid-up capital to API. The transaction became effective on September 3, 2026, following NCLT approval on August 31, 2026. No promoter shareholding changes occurred. The disclosure complies with SEBI takeover regulations.

📊 Stock Analysis — THYROCARE ✨ Ask AI About This

About Thyrocare Technologies Ltd (THYROCARE)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹8,700.77 CrP/E: 49.5ROE: 34.4%ROCE: 45.6%Div Yield: 1.28%

View full THYROCARE stock details →

📡 Get AI alerts when THYROCARE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THYROCARE — Free

💡 Ask AI about this filing

"How does this insider trading affect Thyrocare Technologies Ltd's outlook?""What did Thyrocare Technologies Ltd announce on 4 September 2026?""Is this positive or negative for THYROCARE?"

Ask AI Free →

📊 More THYROCARE filings

🟡 Voting Results — 28 September 2026Thyrocare Technologies proposed two special resolutions via postal ballot: approval to purchase land...
Announcement — 24 September 2026Thyrocare Technologies has closed its insider trading window effective October 1, 2026, until 48 hou...
🟡 Board Meeting — 24 September 2026Thyrocare Technologies approved the grant of 1,92,000 employee stock options at a Rs. 10 exercise pr...
🟡 Board Meeting — 21 September 2026Thyrocare Technologies announced the board approved the sale of its entire 100% stake in radiology s...
🔴 Corporate Action — 21 September 2026Thyrocare Technologies announced on September 21, 2026, that its board approved the sale of its enti...

See all THYROCARE filings →

🔥 Also filed on 4 September 2026

RMCRMC Switchgears LtdAnnual Report 544425AJC Jewel Manufacturers LtdAnnual Report 539255Star Delta Transformers LtdAnnual Report KINETICENGKinetic Engineering LtdAnnual Report WSIW S Industries (India) LtdInsider Trading 544805Jivial Industries LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THYROCARE files new disclosures

Track THYROCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.